Data / Form D filings / Vistim Labs Inc.
Vistim Labs Inc.: Form D filings
Vistim Labs Inc., a biotechnology company in Claymont, DE, filed 5 Form D notices with the SEC between 2023 and 2024. The latest, on October 22, 2024, reports $125,000 sold of a $1.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2093 Philadelphia Pike #3690, Claymont, DE, 19703
- Phone
- (203) 940-3751
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1960015
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2024 | New notice | $1,200,000 | $125,000 | $1,075,000 | 1 | Sep 16, 2024 | sec.gov |
| May 10, 2023 | Amendment | $810,000 | $807,000 | $3,000 | 5 | Dec 19, 2022 | sec.gov |
| Mar 21, 2023 | Amendment | $800,000 | $550,000 | $250,000 | 3 | Dec 19, 2022 | sec.gov |
| Feb 15, 2023 | Amendment | $700,000 | $300,000 | $400,000 | 3 | Dec 19, 2022 | sec.gov |
| Jan 3, 2023 | New notice | $700,000 | $280,000 | $420,000 | 2 | Dec 19, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Zanow | Director | |
| James Hamet | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Oct 21, 2024 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vistim Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.